Summary. Regulatory effects of insulin, somatostatin and cholecystokinin on amino acid transport in the isolated perfused rat pancreas have been studied using a rapid dual isotope dilution technique. Uni-directional L-serine transport (15 s) was quantified relative to an extracellular tracer D-mannitol over a wide range of substrate concentrations. In pancreata perfused with 2.5 mmol/1 D-glucose, a weighted nonlinear regression analysis of overall transport indicated an apparent Km = 14.4 + 1.6 mmol/l and Vmax = 25 9 + 1.4 btmol 9 rain-1, g-1 (n= 6). Although L-serine transport was stimulated during perfusion with 100 ~tU/ml bovine insulin, endogenous insulin (7-25 ng. rain-1.g-1) released during continuous perfusion with either 8.8 mmol/1 or 16.8 mmol/1 D-glucose had no such effect 9 Exogenous somatostatin-14 (250pg/ml) or cholecystokinin octapeptide (CCK-8, 3 x 10-11mol/1) appeared to increase only the Km for transport.
In the rat pancreas, morphological [1] and functional [2, 3] evidence supports the existence of a portal circulation conveying hormones from the islets of Langerhans directly to the basolateral membrane of the exocrine epithelium [4, 5] . The extent of this insulo-acinar portal axis has recently been questioned [6] since rat islets also possess efferent vessels which bypass the exocrine cells and lead directly into the systemic circulation [1, 6] . Although such veins have been identified in 60% of rat islets, most of the efferent vessels from smaller islets within the exocrine lobules appear to be insulo-acinar portal vessels [1] .
Receptors for insulin [5] and somatostatin [7] [8] [9] [10] have been identified on the basolatoral surface on pancreatic acinar cells; however, a direct regulatory action for glucagon remains to be established [11] . Specific receptors for cholecystokinin and other cholinergic secretagogues have also been localised in pancreatic acini [12] . In the isolated perfused rat pancreas, exogenous insulin and endogenous insulin, released during a glucose challenge, potentiate enzyme and juice secretion evoked by cholecystokinin [2] . Recent studies in the perfused rat pancreas examined the effects of reducing endogenous insulin bioavailability on enzyme release induced by caerulein, a cholecystokinin analog [3] .
Pancreatic enzyme secretion was inhibited in the presence of anti-insulin serum and in preparations isolated from insulin deficient streptozotocin-diabetic rats. By contrast, caerulein-induced amylase release was similar in pancreatic acini isolated from normal or diabetic rats, indicating that disruption of the insuloacinar portal axis removes the influence of basal insulin secretion on the exocrine pancreas [3] .
Insulin and streptozotocin-induced diabetes have previously been shown to modulate small, neutral amino acid uptake in the rat pancreas perfused in situ [13] . Stimulation of L-serine transport by bovine insulin was found to be ouabain-insensitive and dependent upon extracellular calcium [14] . Transport was largely mediated by a novel Na+-independent system [15] resembling System asc (alanine, serine, cysteine) described in horse erythrocytes [16] .
The present study was undertaken to determine whether endogenous insulin, released during perfusion of the rat pancreas with 8.8 or 16.8 mmol/1 glucose, could mimick the stimulatory action of exogenous bovine insulin on L-serine transport. As glucose also stimulates release of pancreatic somatostatin [17] [18] [19] [20] [21] [22] , we investigated the effects of exogenous somatostatin-14 on L-serine transport in the absence and presence of 100~U/ml insulin. For comparison, we studied whether cholecystokinin octapeptide (CCK-8), a pancreatic secretagogue known to elevate intracellular Ca 2 +, could influence pancreatic amino acid transport. Abstracts of this work have been presented [23, 24] .
Materials and methods

Animals
Male Sprague-Dawley rats had free access to water and a standard laboratory chow diet (No.491, Grain Harvesters Ltd, Kent, UK). Prior to the experiment, animals (180-220 g) were fasted for 24 h and then anaesthetised between 09.00 and 13.00 hours with an i.p. injection of sodium pentnbarbitone (Sagatal 6 mg/100 g).
Isolation and perfusion of the pancreas
The pancreas was isolated, as described by Kanno et al. [25] , and perfused at constant flow (1.75 ml/min) with a Krebs-Henseleit bicarbonate medium via the coeliac and superior mesenteric arteries with the portal vein as outlet. The isolated preparation was placed in a tissue bath maintained in a temperature controlled (38~ perfusion cabinet [14] . The pancreatic venous effluent was collected from the cannulated portal vein, and flow rate and perfusion pressures were monitored throughout an experiment.
Perfusates
The perfusate had the following composition (mmol/1):NaC1, 131; KCI, 5.6; CaC12, 2.5; MgC12, 1.0; NaHzPO4, 1.0; NaHCO3, 25; D-glucose, 2.5 ; Dextran TT0 (5% w/v, Pharmacia, Milton Keynes, UK); bovine serum albumin (0.25% w/v, Cohn Fraction V, Sigma Chemical Company, Poole, Dorset, UK). Perfusate free of amino acids and dextran was added to the tissue bath (50 ml).
Different concentrations of L-serine (0.05-50 mmol/l) were added to the vascular perfusates to examine the influence of hormones on the kinetics of amino acid transport. Non-specific effects of increased osmolarity could be eliminated, since similar transport rates were measured for L-serine (at 0.05 mmol/1) during perfusion in the absence (40+ 8 nmol-min-l.g-1, n=6) and then presence (36 + 6 nmol. rain-1. g-1) of 50 mmol/l D-mannitol.
Exogenous islet and gastrointestinal hormones Measurement of amino acid uptake and efflux in the exocrine pancreas
Amino acid uptake was measured using a rapid dual isotope dilution technique [26] previously applied to the isolated perfused rat pancreas [13] [14] [15] . Islets comprise only 2%-4% of the pancreatic weight and rapidly oxidise D-glucose [27] , whereas the exocrine pancreas preferentially utilises extracellular amino acids [28] for energy metabolism [27] . Although rat pancreatic islets transport neutral amino acids [29] , rates of influx measured during incubation periods of 2 to 15 min appear at least 2-fold lower than our influx values measured over 15 s in the perfused rat pancreas [15] .
The basolateral pancreatic epithelium would be expected to be the limiting area for exchange in our transport studies, because our pilot studies have shown that D-mannitol and amino acids freely traverse the highly permeable fenestrated capillaries [30] . We have used light microscopic autoradiography to localise cellular sites of L-[3H]serine uptake, and detected a lower silver grain density above peri-islet acini compared to islet-distant acini [311. The absence of silver grains in the vascnlature and interstitium together with the well-known protein synthetic capacity of the exocrine pancreas [30] strongly suggests that the initial uptake of L-serine was mediated by a basolateral plasma membrane carrier(s).
Overall uptake of L-[3H]serine was referred to the dilution profile of an extracellular reference molecule D-[14C]mannitol and simultaneous portal vein tracer concentration-time curves were obtained following a pulsed arterial injection (100 ul/2 s) of perfusate containing both labelled molecules (Fig. 1A) . Twenty to thirty 100 l-tl samples were immediately collected sequentially from the portal vein during 45-60 s, and a final sample was accumulated for a further 4 min to maximise tracer recoveries (data not shown). 
Pancreatic protein output and juice secretion
Pancreatic secretion evoked by CCK-8 was measured using a calibrated silicon tube (0.5 mm external diameter) attached to the free end of the pancreatic duct cannula [2, 25] . The tubing was replaced at 10 min intervals; pancreatic juice volumes were diluted with 0.9% NaC1 containing phosphate buffer (pH 7.1); and total protein was assayed using the method of Lowry et al. [32] , with bovine serum albumin as a standard.
When bovine insulin (100 p~U/ml, Wellcome, Dartford, UK), somatostatin-14 (250 pg/ml, Peninsula Laboratories, Merseyside, UK), or cholecystokinin octapeptide (3x10-11mol/l sulphated CCK-8, Peninsula) were added to the perfusates, pancreata were initially preperfused for 20-25 rain with the hormone(s). L-serine transport was then measured in the continued presence of hormone(s). Solutions were gassed with 95% 02/5% CO2 at 38~ to a pH between 7.3-7.4.
Insulin and glucagon radioimmunoassays
Samples of the pancreatic venous outflow were collected at 1-or 2-min intervals into chilled tubes containing 30 pJ aprotonin (Trasylol, Bayer, Newbury, UK) and frozen at -20~ until the time of assay. [33] ; the limit of detection for these assays was 0.08 ng/ml for insulin and 78 pg/ml for glucagon.
Radioactive molecules and counting procedures
The radioactive molecules L-[3-3Hlsefine (0. 
Statistical analysis
Data are expressed as means___ SEM of measurements in number of animals. Analyses were performed using the two-tailed Student's t-test for unpaired data. Bovine insulin, and/or somatostatin-14 or CCK-8 were added to the perfusates and pancreata were pre-perfused for 20-25 min before measuring the kinetics of L-serine influx in the continued absence or presence of the hormone(s). The tabulated kinetic constants were calculated using a weighted Michaelis-Menten analysis Kinetics of uni-directional L-serine influx (1-50 retool/l) were measured after this 20-25 min exposure period and during continued perfusion with the above solutions. Michaelis-Menten kinetics were estimated by directly fitting a single weighted rectangular hyperbola to the three sets of mean influx values. Mean influx data were weighted for the reciprocal of their respective standard errors and the vertical lines denote the SEM at each concentration in 4-7 perfused pancreata. ], L = plus or minus SEM od (Table 1 ). Even at this low substrate concentration effiux of L-[3H]serine was 61 ___ 3%. Thin-layer chromatographic analysis of the pancreatic effluent confirmed that 5 min after a tracer injection the tritium activity was still associated with native L-serine (data not shown).
Results
Self-inhibition of L-serine transport
Uni-directional and net tracer uptakes were reduced by increasing substrate concentration suggesting cis-inhibition ( Table 1) . The kinetics of self-inhibition are shown in Figure 2 , and exposure to 10 mmol/1 L-serine reduced influx to 45 + 5% of control values. Increasing the extracellular L-serine also enhanced tracer efflux (Table 1) 
Effects of exogenous insulin
L-serine transport in the presence of 2.5 mmol/1 D-glucose was saturable ( Fig. 3) with an apparent Km=14.4mmol/1 and Vmax=25.91xmol.min-t.g -1 ( Table 2 ). This gma x value is higher than that measured previously in the pancreas perfused in situ with 5.5 mmol/1 D-glucose and 1% bovine albumin [13] . In other experiments, pancreata were perfused for 20-25 min with 2.5 mmol/1 glucose and J00 ~U/ml bovine insulin. Thereafter, the ldnetics of L-serine transport were measured during a further 40-60 min perfusion with 2.5 mmol/1 glucose and 100 gU/ml bovine insulin. Under these conditions, L-serine transport capacity (Vma~ = 57.1 gmol-min -t-g-t) was increased; whereas the transport affinity (Km = 29.8 mmol/1) was lowered ( Table 2 ). Exogenous insulin had no effect on perfusion pressure or flow rate (data not shown). Islet hormone release was not monitored in experiments with insulin.
Effects of endogenous insulin released by a vascular D-glucose challenge
We then investigated whether release of endogenous insulin could mimick the stimulatory effect of bovine insulin on L-serine transport. After a pre-equilibration period with 2.5 mmol/1 glucose, pancreata were per-fused for 20-25 min with 2. 5, 8.8 or 16.8 mmol/1 glu- 
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cose. Perfusion with each glucose concentration was then continued for another 40-60 min, and kinetic experiments were only performed after 20-25 min exposure to each glucose concentration. This experimental design mimicks the pre-perfusion period with bovine insulin. Figure 4 illustrates the effects of challenging preequilibrated pancreata (2.5 mmol/1 glucose) with either 8.8 or 16.8 mmol/1 glucose. The latter glucose concentration evoked the characteristic and well-documented biphasic release of immunoreactive insulin (IRI) and, as previously reported [14] , inhibited immunoreactive glucagon (IRG) release. IRI levels in the pancreatic venous effluent were maintained above 20ng.min-a.g -1 (approx 275-300~tU/ml) for over 40 min, confirming earlier reports of long term glucose stimulation of insulin release from the perfused rat pancreas [35] . IRI levels were maintained between 5-12ng-min-t.g -1 during 60rain perfusion with 8.8 mmol/1 glucose (Fig.4) . These latter portal vein levels of endogenous insulin are marginally higher than the 6-7ng.min-l-g -1 achieved during infusion of 100 ~tU/ml bovine insulin.
Surprisingly, kinetics of L-serine transport were similar in the presence of 2.5, 8.8 (data not shown) or 16.8 mmol/1 glucose (Fig. 3) . L-serine influx (10 mmol/1) during continued perfusion with 2.5 or 8.8 mmol/1 glucose was respectively, 12.9+1.1 txmol .min-t .g-1 and 13.2+0.6 ~tmol .min -t .g-t (n= 3).
Release of IRI and IRG was examined in more detail at different glucose and L-serine concentrations. Table 3 summarises these findings, and at 2.5 mmol/1 2.5 glucose insulin release was low compared to an ele-2.5 vated release of glucagon. Subsequent perfusion with 8.8 8.8 10 mmol/1 L-serine had no effect on IRI release but en- 16.8 hanced IRG release. This amino acid-induced stimula-16.8 tion of IRG release was transient and values returned to 16.8 control levels after 8 min exposure to 10 mmol/1 Lserine [14] . In the presence of 8.8 mmol/1 glucose, IRI release increased and IRG release decreased. Under these conditions, 10 mmol.1 -t L-serine further enhanced IRI release and inhibited IRG release. IRI release was markedly stimulated by 16.8 mmol/1 glucose and L-serine, whereas IRG release remained essentially unaltered except in the presence of 50 mmol/1 L-serine. 
Inhibition of insulin action by exogenous somatostatin-14
Previous studies in the isolated rat pancreas have shown that somatostatin is released with insulin during a vascular D-glucose challenge [17] [18] [19] [20] [21] [22] . We have also noted an increase in immunoreactive somatostatin ($14) release from < 10 pg/ml to more than 50 pg/ml during perfusion of the rat pancreas with 8.8 mmol/1 glucose.
As in the case of bovine insulin, transport kinetics were examined during continuous perfusion with exogenous somatostatin-14 (250 pg/ml). This concentration is near the maximal level detected in the perfused rat pancreas [20] . Although the Km (19.6 mmol/1) for transport increased, there was no significant change in the transport rate (Table 2) . When preparations were perfused with exogenous bovine insulin (100 IxU/ml) and somatostatin-14 (250 pg/ml), the ]previously observed stimulation of Lserine transport by insulin (Fig. 3) was fully inhibited. The Kn, for transport was not different from that observed with somatostatin-14 alone, whereas Vma• was reduced below control rates (Table 2) . Moreover, the transport index Vmax/Km was decreased from a control value of 1.79 to 0.86.
Effects of exogenous choleeystokinin octapeptide
For comparison, we examined whether the pancreatic secretagogue CCK-8 -known to bind to specific acinar cell receptors -stimulated L-serine transport. Dose response curves for CCK-8 evoked pancreatic protein output and juice flow are shown in Figure 5 . The time course of changes in total protein and juice secretion evoked by 3x10-11mol/1 CCK-8 are shown in Figure 6 . Unlike with exogenous insulin, L-serine transport was largely unaffected by CCK-8 ( Table 2 ). The reported inhibitory effect of CCK-8 on somatostatin binding in pancreatic acini [7--9] and the fact that CCK-8 stimulates release of insulin, glucagon and somatostatin from the islets of Langerhans [22, 35, 36] dissuaded us from studying interactions between CCK-8 and other exogenous hormones.
Discussion
In the present study, pancreatic amino acid transport was stimulated by exogenous bovine insulin but paradoxically unaffected by insulin released from the endocrine pancreas during a prolonged vascular D-glucose challenge. Although perfusion with somatostatin-14 or CCK-8 alone only marginall[y altered the kinetics of L-serine transport, the stimulatory action of exogenous insulin was abolished in the presence of exogenous somatostatin.
Immunoreactive insulin levels ranged from < 1 to 25 ng. min-l, g-1 during perfusion of the pancreas with 2.5, 8.8 and 16.8 mmol/1 glucose. Although supramaximal hormone levels are often inhibitory [3, 5, 12] , such insulin levels have been detected in the effluent of the rat pancreas during a prolonged vascular glucose challenge [37] . In our work 8.8 mmol/1 glucose evoked an insulin release in the range achieved during perfusion with bovine insulin, and yet amino acid transport was not stimulated.
Functional evidence supports the existence of a pancreatic insulo-acinar portal circulation [2, 3] . Exogenous rat insulin (1-20 ~tU/ml) and endogenous insulin (232 lxU/ml) released during perfusion with 17.5 mmol/l D-glucose potentiated CCK evoked exocrine secretion [2] . Since a non-recirculating perfusion system was used in this study, it appears that insulin modulates exocrine function without entering the systemic circulation [2, 5] . Elevated glucose may have affected glucagon and somatostatin release from the endocrine pancreas [2] . Recent studies in the isolated pancreas have confirmed that glucose stimulates insulin and somatostatin release but inhibits glucagon release from the endocrine pancreas [17] [18] [19] [20] [21] [22] . On going experiments in our laboratory revealed that human glucagon (10-gmol/1) has no effect on L-serine transport (data not shown).
Somatostatin-14 is known to bind to specific acinar cell membrane receptors [7, 10] by a calcium-dependent mechanism [8, 9] . It is interesting that the stimulatory action of insulin on pancreatic L-serine transport is abolished upon removal of extracellular calcium [14] . In cultured rat myoblasts, somatostatin reduces insulinstimulated leucine and aminoisobutyric acid (2-AIB) uptake but has no effect on basal uptake of these substrates, suggesting that circulating insulin and somatostatin may have antagonistic effects on nutrient uptake into cells [38] . In the pancreas, somatostatin similarly reduced insulin-stimulated L-serine transport but had little effect on basal uptake (Table 2) . Somatostatin-14 binding sites have been identified on A and B cells in cultured rat islets [39] , and low doses of exogenous somatostatin may increase glucagon and insulin release by suppressing endogenous somatostatin release, whereas higher doses mask this effect by directly inhibiting A-und B-cell function [40] .
Activation of protein kinase C by phorbol esters (TPA) or diacylglycerol reduces somatostatin binding in pancreatic acini, but the time course of inhibition is longer than that observed for inhibition of insulin binding [41] . The cellular mechanisms by which somatostatin inhibits insulin action in the exocrine pancreas merit further study. Perhaps protein kinase C may be one of the factors modulating islet hormone interactions at the basolateral plasma membrane of the exocrine pancreatic epithelium.
In summary, pancreatic L-serine transport mediated by the Na+-independent System asc is sensitive to interactions between insulin and somatostatin. Characteristics and kinetics of this transporter differ from the classical Na +-dependent System A mediating Lalanine uptake in pancreatic acini [42] . Lack of an effect with endogenous insulin may reflect efferent vessels leading from the islets directly into the systemic circulation [1, 6] ; however, our results are consistent with another hypothesis. If somatostatin were released together with insulin during a vascular D-glucose challenge [17] [18] [19] [20] [21] [22] and conveyed to the exocrine pancreas via insulo-acinar portal vessels [1] , it is possible that somatostatin regulates the stimulatory actions of insulin on exocrine pancreatic amino acid transport.
